Skip to main content

Advertisement

SpringerLink
Log in

Local control of osteoclast function

  • Session VII: Pathogenesis: Bone Cells, Hormones And Growth Factors
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Yoneda T, Kato I, Bonewald LF, Chisoku H, Burgess WH, Mundy GR. A novel osteoclastpoietic peptide: purification and characterization. J Bone Miner Res 1991;6:[suppl]:abstr 454.

  2. Yoneda T, Alsina MM, Chavez JB, et al. Evidence that splenic cytokines play a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia and luekocytosis in a human tumor in nude mouse. J Clin Invest 1991;87:977.

    Google Scholar 

  3. Lee MY, Eyre DR, Osborne WR. Isolation of a murine osteoclast colony-stimulating factor. Proc Natl Acad Sci USA 1991;88:8500.

    Google Scholar 

  4. Yoshida H, Hayashi SI, Kunisada T, Ogawa M, Nishikawa S, Okamura H, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990;345:442–4.

    Google Scholar 

  5. Felix R, Cecchini MG, Fleisch H. Macrophage colony stimulating factor restores in vivo bone resorption in theop/op osteopetrotic mouse. Endocrinology 1990;127:2592–4.

    Google Scholar 

  6. Takahashi N, Udagawa N, Akatsu T, Tanaka H, Isogai Y, Suda T. Deficiency os osteoclasts in osteopetrotic mice is due to a defect in the local microenvironment provided by osteoblastic cell. Endocrinology 1991;128:1792–6.

    Google Scholar 

  7. Mundy GR. Malignancy and hypercalcemia: humoral hypercalcemia of malignancy, hypercalcemia associated with osteolytic metastases. In: Calcium homeostasis: hypercalcemia and hypocalcemia. London: Martin Dunitz, 1990:69–99.

    Google Scholar 

  8. Sato K, Fujii Y, Kasono K. Parathyroid hormone-related protein and interluekin-1α synergetically stimulate bone resorption in vivo and increase serum calcium concentration in mice in vivo. Endocrinology 1989;124:2172.

    Google Scholar 

  9. Fried RM, Voelkel EF, Rice RH, et al. Two squamous cell carcinoma not associated with humoral hypercalcemia produce a potent bone resorption-stimulating factor which is interleukin-1 alpha. Endocrinology 1989;125:742.

    Google Scholar 

  10. Pacifici R, Rifas L, Teitelbaum S, Slatopolsky E, McCracken R, Bergfeld M, et al. Spontaneous release of interluekin-1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci USA 1987;84:4616–20.

    Google Scholar 

  11. Pacifici R, Rifas L, McCracken R, Vered I, McMurty C, Avioli L, Peck WA. Ovarian steroid treatment blocks a postmenopausal increase in blood moncyte interluekin-1 release. Proc Natl Acad Sci USA 1989;86:2398–402.

    Google Scholar 

  12. Soriano P, Montgomery C, Geske R, et al. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991;64:693–702.

    Google Scholar 

  13. Kato I, Yoneda T, Izbicka E, Lee C, Gutierrez G, Boyce B, et al. Osteoclasts deficieny in c-src tyrosine kinase fail to resorb bone in vitro and in vivo. J Bone Miner Res 1991;6:[Suppl]:abstr 452.

Download references

Author information

Authors and Affiliations

  1. Health Science Center, University of Texas, San Antonio, Texas, USA

    R. Mundy

Authors
  1. R. Mundy
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mundy, R. Local control of osteoclast function. Osteoporosis Int 3 (Suppl 1), 126–127 (1993). https://doi.org/10.1007/BF01621885

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01621885

Keywords

Search

Navigation